Recombinant human coagulation Factor VIIa (rFVIIa) is used to treat hemorrhagic problems caused by hemophilia A and B. It promotes hemostasis by triggering the pathway of the coagulation cascade.
Recombinant human coagulation Factor VIIa (rFVIIa) is used to treat hemorrhagic problems caused by hemophilia A and B. It promotes hemostasis by triggering the pathway of the coagulation cascade.
For treatment of hemorrhagic complications in hemophilia A and B
Do not give this drug to people with the following conditions:
Recombinant Coagulation Factor VIIA may have the following side effects:
Precautions
Take extra caution in patients with the following medical conditions:
Interactions
Recombinant Coagulation Factor VIIA may interact with the following medicines:
If you think you have used more Recombinant Coagulation Factor VIIA than the usual dosage, please seek medical help immediately.
Available Brands:
Nasea is a medication that contains ondansetron as its active ingredient. Ondansetron is a selective serotonin 5-HT3 receptor antagonist commonly [...]
Maxicap is a nutritional supplement that combines multivitamins with lysine, an essential amino acid. It is formulated to provide a [...]
Maxeftin is a potent antibiotic medication used to treat a variety of bacterial infections. It belongs to the cephalosporin class [...]